Cargando…

Differential Clinical Benefit With Contemporary Drug-Eluting Stents: Fact or Fancy?

[Figure: see text]

Detalles Bibliográficos
Autor principal:	Kereiakes, Dean J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627792/ https://www.ncbi.nlm.nih.gov/pubmed/36339116 http://dx.doi.org/10.1016/j.jacasi.2021.12.001

Ejemplares similares

Facts and Fancies
Publicado: (1897)

Facts and Fancies
Publicado: (1897)

Nanobacteria: Facts or Fancies?
por: Urbano, Pasquale, et al.
Publicado: (2007)

Housing Facts and Fancy
Publicado: (1920)

Fad, Fact and Fancy in Medicine
por: King, Clarence
Publicado: (1900)

False Issues and Fanciful Facts
Publicado: (1888)

Hematophagous Endeavors, Fact and Fancy
por: Breedlove, Byron, et al.
Publicado: (2017)

Fact and fancy in neutrino physics
por: De Rújula, Alvaro, et al.
Publicado: (1973)

The Case of Moulay Ismael - Fact or Fancy?
por: Oberzaucher, Elisabeth, et al.
Publicado: (2014)

Probiotics and vaginal microecology: fact or fancy?
por: Buggio, Laura, et al.
Publicado: (2019)

Effectiveness and Safety of Contemporary Drug-Eluting Stents in Patients With Diabetes Mellitus
por: Yang, Yujin, et al.
Publicado: (2021)

Hepato-biliary stem cells: facts and fancies
por: Theise, Neil D
Publicado: (2014)

Assessment of anti-dislodgment capability for contemporary drug eluting stents
por: Ye, Yicong, et al.
Publicado: (2021)

Stent Thrombosis and Restenosis with Contemporary Drug-Eluting Stents: Predictors and Current Evidence
por: Condello, Francesco, et al.
Publicado: (2023)

Biodegradable polymer everolimus-eluting stents versus contemporary drug-eluting stents: a systematic review and meta‑analysis
por: Yin, Juntao, et al.
Publicado: (2023)

Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis
por: Navarese, Eliano P, et al.
Publicado: (2013)

Role of Immunologic Disturbance in Human Oncogenesis: Some Facts and Fancies*
por: Kaplan, Henry S.
Publicado: (1971)

Comparison of Contemporary Drug-Eluting Stents in Patients Undergoing Complex High-Risk Indicated Procedures
por: Jeong, Yeong Jin, et al.
Publicado: (2022)

Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis
por: Wang, Guozhong, et al.
Publicado: (2019)

Two-year Clinical Outcomes of Patients with Long Segments Drug-Eluting Stents: Comparison of Sirolimus-Eluting Stent with Paclitaxel-Eluting Stent
por: Kim, Ung, et al.
Publicado: (2011)

Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug-Eluting Stents
por: Faramarzi, Negar, et al.
Publicado: (2013)

Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis
por: Nojima, Yuhei, et al.
Publicado: (2014)

Drug-Eluting Stents: Technical and Clinical Progress
por: Koźlik, Maciej, et al.
Publicado: (2023)

Transradial versus transfemoral rotablation for heavily calcified coronary lesions in contemporary drug-eluting stent era
por: Yin, Wei-Hsian, et al.
Publicado: (2015)

Final 5‐Year Report of the Randomized BIO‐RESORT Trial Comparing 3 Contemporary Drug‐Eluting Stents in All‐Comers
por: Ploumen, Eline H., et al.
Publicado: (2022)

Late outcomes of renal denervation are more favourable than early ones: facts or fancies?
por: Persu, Alexandre, et al.
Publicado: (2023)

Clinical Outcomes of Drug-Eluting versus Bare-Metal In-Stent Restenosis after the Treatment of Drug-Eluting Stent or Drug-Eluting Balloon: A Systematic Review and Meta-Analysis
por: Yang, Yi-Xing, et al.
Publicado: (2020)

The efficacy and safety of drug-eluting balloons for the treatment of in-stent restenosis as compared with drug-eluting stents and with conventional balloon angioplasty
por: Oh, Pyung Chun, et al.
Publicado: (2016)

Optimization of Drug Delivery by Drug-Eluting Stents
por: Bozsak, Franz, et al.
Publicado: (2015)

Polymer-free drug-eluting stents versus permanent polymer drug-eluting stents: An updated meta-analysis
por: Chen, Yun-lin, et al.
Publicado: (2019)

Is There an Advantage of Ultrathin-Strut Drug-Eluting Stents over Second- and Third-Generation Drug-Eluting Stents?
por: Gherasie, Flavius-Alexandru, et al.
Publicado: (2023)

Ureteral stent technology: Drug-eluting stents and stent coatings
por: Yang, Luo, et al.
Publicado: (2015)

Facts and Fancies in Orthopaedics: Kenneth Pridie Memorial Lecture Truro, 13th May, 1967
por: Capener, Norman
Publicado: (1968)

Intracoronary brachytherapy for in-stent restenosis of drug-eluting stents
por: Ohri, Nisha, et al.
Publicado: (2015)

Drug-eluting metallic stents in urology
por: Kallidonis, Panagiotis S., et al.
Publicado: (2014)

The Effect of Cilostazol on Stent Thrombosis After Drug-Eluting Stent Implantation
por: Jeon, Doo-Soo, et al.
Publicado: (2010)

Fancy & imagination
por: Brett, R. L.
Publicado: (1969)

Fancy Fees
Publicado: (1888)

Real-World Three-Year Clinical Outcomes of Biolimus-Eluting Stents versus Other Contemporary Drug-Eluting Stents in Patients with Acute Myocardial Infarction Patients: Data from the Korea Acute Myocardial Infarction Registry (KAMIR)
por: Park, Ji Young, et al.
Publicado: (2021)

Drug Release Analysis and Optimization for Drug-Eluting Stents
por: Li, Hongxia, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_gbiu0numj0tcg5f5bdsrtnvtho